Acute Ischemic Stroke - Pipeline Review, H2 2016; New Report Launched
Acute Ischemic Stroke pipeline therapeutics constitutes close to 27 molecules. Out of which approximately 27 molecules are developed by Companies. Global Markets Direct's latest report Acute Ischemic Stroke – Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Acute Ischemic Stroke, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
View full press release